To The Main Page
About RTC Our Projects Stem Cell Therapy Research Translation Service/Technology Transfer Contact
   Advisory Board
The Translation Advisory Board provides advice and recommendations to the RTC particularly on the joint research project „Added value in regenerative medicine – a pioneering approach to remove translation barriers“. The composition of the advisory board reflects the complexity of the project. The inaugural meeting of the Translation Advisory Board took place on June 12th, 2010, at the RTC .

Members of the Translation Advisory Board are:

Prof. Dr. med. Dr. iur. Christian Dierks

Christian Dierks studied Medicine at the universities of Regensburg, Hamburg and Cape Town, South of Africa. After completing his doctorate (Dr. med.) in 1987 at the University of Hamburg, Christian Dierks studied Law at the University of Regensburg and at the Ludwig-Maximilians-University in Munich between 1988 and 1990. As a law clerk at the Ludwig-Maximilians-University in Munich he completed his doctorate in jurisprudence (Dr. jur.) in 1992. Christian Dierks works as a general practitioner and social lawyer. Since his habilitation degree in 1999 he has been lecturing at the Center for Humanities and Health Sciences of the Charité - Universitätsmedizin Berlin. In his law firm Dierks+Bohle in Berlin he is responsible for the fields of pharmaceutical law, judicial issues of statutory health insurance and telemedicine as well as the physicians' professional law.


Prof. Dr. med. Frank Emmrich

Frank Emmrich studied Human Medicine at the University of Leipzig where he completed his doctorate in the field of immunology. His scientific career led him to Heidelberg, Freibug, Erlangen and finally back to Leipzig where he was appointed as Professor of Clinic Immunology in 1994 and as Director of the Institute for Clinical Immunology of the University of Leipzig. The focus of his work is: autoimmunity, immuno- and cell-therapy, transplantation immunology, stem cells and cell-technology, therapy development, and clinical tests. Since 2005 Frank Emmrich has been the director of the newly founded Fraunhofer Institute for Cell Therapy and Immunology (IZI) of Leipzig. Furthermore, he has been heading the Translational Center for Regenerative Medicine (TRM) of Leipzig since 2006. Frank Emmrich has also been a member of the German Ethics Council since 2008.


Dr. med. Wolfgang Ingenhag

Wolfgang Ingenhag studied Human Medicine at the Ludwig-Maximilian-University (LMU) in Munich where he completed his doctorate in Pathology about multiple primary tumors. After a broad medical education, he has been practicing in clinical research in the pharmaceutical industry for several years. After further education in health economics, Wolfgang Ingenhag became head of the division of medicine/quality assurance at the German Association of Company Health Insurance Fund in the beginning of 1993. Furthermore, Wolfgang Ingenhag has been lecturing at the Institute for General Medicine of the Medical Faculty, University of Duisburg-Essen, since 1995.


Prof. Dr. Christa Schröder

Christa Schröder studied Pharmacy at the Carolo-Wilhelmina-Universiy of Braunschweig. After receiving her license to practice medicine she completed her doctorate in pharmaceutic technology. Between 1990 and 1998 Christa Schröder acted as Qualified Person and Regulatory Specialist in industry. Between 1998 and 2009 she worked at the Paul Ehrlich Institute in the field of European Authorization and Advanced Therapy Medicinal Products. She represented the Federal Republic of Germany in several European committees, such as the Coordination Group for Mutual Recognition and Decentralised Procedures (CMD(h)) at EMA, Coding of Information and Traceability of Human Tissues and Cells at the European Commission for Standardization (CEN) in Brussels. She also was a member of the working group European Single Coding for Tissues and Cells at DG SANCO in Brussels.
In September 2009, Christa Schröder was appointed as Professor of Quality Assurance in Pharmaceutical Technology, Pharmaceutical Law and Regulatory Affairs at the University of Albstadt-Sigmaringen.


Prof. Dr. med. Hans-Dieter Volk

Hans-Dieter Volk studied Human Medicine at the Humboldt University of Berlin. After graduating in 1980 he was awarded a doctorate in Medicine (Dr. med.) at the Charité in Berlin. He worked as an assistant physician and as a research associate at the Institute for Medical Immunology at the Charité in Berlin as well as in Leipzig, Jena and Rostock.
After his specialist training (1986) and habilitation degree (1987) in Clinical Immunology and research fellowship in Innsbruck (Prof. Ch. Huber) and at the Freie Universität of Berlin (Prof. Diamantstein), Hans-Dieter Volk assumed the leadership of the Institute for Medical Immunology at the Charité in Berlin in 1994. Since 2006 he has been the Director of the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and since 2007 he has been the deputy speaker of the Berlin-Brandenburg School for Regenerative Therapies (BSRT).



Legal The RTC is supported by the BMBF and the State Mecklenburg-Western Pomerania using EU Structural Funds.